{"pmid":32257772,"pmcid":"PMC7104689","title":"Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.","text":["Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.","Objectives: Case fatality rates (CFR) and recovery rates are important readouts during epidemics and pandemics. In this article, an international analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic. Methods: Data were retrieved from accurate databases according to the user's guide of data sources for patient registries, CFR and recovery rates were calculated for each country. A comparison of CFR between countries with total cases >/= 1,000 was observed for 12(th) and 23(rd) March. Results: Italy's CFR was the highest of all countries studied for both time points (12(th) March, 6.22% versus 23(rd) March, 9.26%). The data showed that even though Italy was the only European country reported on 12(rd) March, Spain and France had the highest CFR of 6.16 and 4.21%, respectively, on 23(rd) March, which was strikingly higher than the overall CFR of 3.61%. Conclusion: Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease.","Osong Public Health Res Perspect","Khafaie, Morteza Abdullatif","Rahim, Fakher","32257772"],"abstract":["Objectives: Case fatality rates (CFR) and recovery rates are important readouts during epidemics and pandemics. In this article, an international analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic. Methods: Data were retrieved from accurate databases according to the user's guide of data sources for patient registries, CFR and recovery rates were calculated for each country. A comparison of CFR between countries with total cases >/= 1,000 was observed for 12(th) and 23(rd) March. Results: Italy's CFR was the highest of all countries studied for both time points (12(th) March, 6.22% versus 23(rd) March, 9.26%). The data showed that even though Italy was the only European country reported on 12(rd) March, Spain and France had the highest CFR of 6.16 and 4.21%, respectively, on 23(rd) March, which was strikingly higher than the overall CFR of 3.61%. Conclusion: Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease."],"journal":"Osong Public Health Res Perspect","authors":["Khafaie, Morteza Abdullatif","Rahim, Fakher"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32257772","week":"202015|Apr 06 - Apr 12","doi":"10.24171/j.phrp.2020.11.2.03","keywords":["COVID-19","case fatality rates","coronavirus"],"source":"PubMed","locations":["Spain","European","France","Italy"],"countries":["France","Italy","Spain"],"countries_codes":["FRA|France","ITA|Italy","ESP|Spain"],"topics":["Diagnosis"],"weight":1,"_version_":1663450393520111617,"score":7.9164424,"similar":[{"pmid":32234343,"pmcid":"PMC7102547","title":"Monitoring Transmissibility and Mortality of COVID-19 in Europe.","text":["Monitoring Transmissibility and Mortality of COVID-19 in Europe.","OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority.","Int J Infect Dis","Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin","32234343"],"abstract":["OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority."],"journal":"Int J Infect Dis","authors":["Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234343","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijid.2020.03.050","keywords":["COVID-19","Control","Europe","effective reproduction numbers"],"source":"PubMed","locations":["Germany","Italy","France","Spain"],"countries":["France","Italy","Germany","Spain"],"countries_codes":["FRA|France","ITA|Italy","DEU|Germany","ESP|Spain"],"topics":["Epidemic Forecasting","Transmission","Prevention"],"weight":1,"_version_":1663352135632289792,"score":578.07086},{"pmid":32175421,"pmcid":"PMC7049028","title":"Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","text":["Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).","Ann Transl Med","Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai","32175421"],"abstract":["Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)."],"journal":"Ann Transl Med","authors":["Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32175421","week":"202012|Mar 16 - Mar 22","doi":"10.21037/atm.2020.02.66","keywords":["2019 novel coronavirus","COVID-19","case fatality rate (CFR)","severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)"],"source":"PubMed","locations":["Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1663352133895847937,"score":472.78116},{"pmid":32235086,"title":"As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","text":["As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.","J Infect Dev Ctries","Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David","32235086"],"abstract":["COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities."],"journal":"J Infect Dev Ctries","authors":["Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235086","week":"202014|Mar 30 - Apr 05","doi":"10.3855/jidc.12734","keywords":["*COVID-19","*Case Fatality Rates","*Immunity","*Italy","*Novel coronavirus","*SARS-CoV-19"],"source":"PubMed","locations":["Italy","China"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1663352135543160834,"score":449.25604},{"pmid":32234121,"title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.","text":["Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.","Adjusting for delay from confirmation to death, we estimated case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% (95% confidence interval (CI): 0.89-6.7) and 1.3% (95% CI: 0.38-3.6), respectively. Comparing deaths on board with expected deaths based on naive CFR estimates from China, we estimated CFR and IFR in China to be 1.2% (95% CI: 0.3-2.7) and 0.6% (95% CI: 0.2-1.3), respectively.","Euro Surveill","Russell, Timothy W","Hellewell, Joel","Jarvis, Christopher I","van Zandvoort, Kevin","Abbott, Sam","Ratnayake, Ruwan","Cmmid Covid-Working Group","Flasche, Stefan","Eggo, Rosalind M","Edmunds, W John","Kucharski, Adam J","32234121"],"abstract":["Adjusting for delay from confirmation to death, we estimated case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% (95% confidence interval (CI): 0.89-6.7) and 1.3% (95% CI: 0.38-3.6), respectively. Comparing deaths on board with expected deaths based on naive CFR estimates from China, we estimated CFR and IFR in China to be 1.2% (95% CI: 0.3-2.7) and 0.6% (95% CI: 0.2-1.3), respectively."],"journal":"Euro Surveill","authors":["Russell, Timothy W","Hellewell, Joel","Jarvis, Christopher I","van Zandvoort, Kevin","Abbott, Sam","Ratnayake, Ruwan","Cmmid Covid-Working Group","Flasche, Stefan","Eggo, Rosalind M","Edmunds, W John","Kucharski, Adam J"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234121","week":"202014|Mar 30 - Apr 05","doi":"10.2807/1560-7917.ES.2020.25.12.2000256","keywords":["*COVID-19","*Case fatality ratio","*asymptomatic","*coronavirus","*cruise ship","*infection fatality ratio","*outbreak","*severity"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1663352135519043584,"score":424.8225},{"pmid":32179124,"pmcid":"PMC7102608","title":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.","text":["Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.","INTRODUCTION: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. METHODS: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). RESULTS: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). CONCLUSION: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19.","Travel Med Infect Dis","Rodriguez-Morales, Alfonso J","Cardona-Ospina, Jaime A","Gutierrez-Ocampo, Estefania","Villamizar-Pena, Rhuvi","Holguin-Rivera, Yeimer","Escalera-Antezana, Juan Pablo","Alvarado-Arnez, Lucia Elena","Bonilla-Aldana, D Katterine","Franco-Paredes, Carlos","Henao-Martinez, Andres F","Paniz-Mondolfi, Alberto","Lagos-Grisales, Guillermo J","Ramirez-Vallejo, Eduardo","Suarez, Jose A","Zambrano, Lysien I","Villamil-Gomez, Wilmer E","Balbin-Ramon, Graciela J","Rabaan, Ali A","Harapan, Harapan","Dhama, Kuldeep","Nishiura, Hiroshi","Kataoka, Hiromitsu","Ahmad, Tauseef","Sah, Ranjit","32179124"],"abstract":["INTRODUCTION: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. METHODS: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). RESULTS: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). CONCLUSION: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19."],"journal":"Travel Med Infect Dis","authors":["Rodriguez-Morales, Alfonso J","Cardona-Ospina, Jaime A","Gutierrez-Ocampo, Estefania","Villamizar-Pena, Rhuvi","Holguin-Rivera, Yeimer","Escalera-Antezana, Juan Pablo","Alvarado-Arnez, Lucia Elena","Bonilla-Aldana, D Katterine","Franco-Paredes, Carlos","Henao-Martinez, Andres F","Paniz-Mondolfi, Alberto","Lagos-Grisales, Guillermo J","Ramirez-Vallejo, Eduardo","Suarez, Jose A","Zambrano, Lysien I","Villamil-Gomez, Wilmer E","Balbin-Ramon, Graciela J","Rabaan, Ali A","Harapan, Harapan","Dhama, Kuldeep","Nishiura, Hiroshi","Kataoka, Hiromitsu","Ahmad, Tauseef","Sah, Ranjit"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32179124","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.tmaid.2020.101623","keywords":["Clinical features","Coronavirus disease 2019","Epidemic","Laboratory","Outcomes","SARS-CoV-2"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352133869633536,"score":421.75146}]}